How to Label Korean Skincare for the US Market: 2026 FDA Compliance Guide
By Liz Song, K-beauty sourcing consultant
Your Korean ODM just shipped the final packaging proof. The design is gorgeous. The serum inside smells like a Jeju orchard. You are three weeks from your Amazon launch date. And then your freight forwarder calls: Customs flagged your entire shipment for labeling violations. The hold fee is $1,200 a day, and your influencer launch campaign starts next Monday.
This is not a hypothetical. It happens to first-time K-beauty founders more often than anyone in the industry likes to admit. The gap between Korean labeling conventions and US FDA requirements is wide enough to swallow an entire product launch. This guide covers the seven labeling rules that trip up founders most, with specific fixes you can hand directly to your ODM's packaging team.
Quick Answer: US FDA requires 8 specific elements on Korean skincare labels including product identity, net contents, INCI ingredient list, manufacturer details, and country of origin. Under 2026 MoCRA rules, facility registration and product listing are also mandatory. Most customs holds stem from INCI translation errors and missing bilingual label elements.
Key Takeaways
- If your packaging has any Korean text, the FDA requires all mandatory label information to also appear in Korean, not just English. Most founders learn this at customs.
- Korean COA ingredient names and US INCI names are not the same thing. Your ingredient list needs conversion before printing.
- Sunscreen products are classified as OTC drugs in the US, requiring a Drug Facts panel. Korea classifies them as cosmetics.
- MoCRA now requires a US-based responsible person with domestic contact information on every cosmetic label.
- A pre-shipment label audit costs a few hundred dollars. A customs hold costs thousands per day plus your launch timeline.
The Bilingual Label Trap Most Founders Walk Into
Here is the rule that catches everyone: under the Federal Food, Drug, and Cosmetic Act (FD&C Act), if your label contains any representation in a foreign language, all required label information must also appear in that foreign language. Read that again. It does not say "just put English on there and you are fine." It says if you keep any Korean text on the packaging, you now need to duplicate every FDA-required element in Korean too.
Why does this matter so much for K-beauty? Because Korean ODMs design packaging for the Korean domestic market first. That packaging has Korean text everywhere: the brand story on the back panel, the usage instructions, sometimes even a cute marketing tagline on the front. Founders love the aesthetic and want to keep it. Totally understandable. But the moment you ship that mixed-language package to the US without duplicating your INCI list, net weight, warnings, and responsible person info in Korean, you are technically non-compliant.
The simplest fix: create a US-specific packaging version with English only. If you want to keep Korean text for brand authenticity, budget for a full bilingual compliance review. Do not assume your ODM's in-house packaging team knows US rules. They are experts in MFDS (Korea's Ministry of Food and Drug Safety) regulations, which are a completely different framework.
What Exactly Does the FDA Require on a Cosmetic Label?
Every cosmetic label sold in the US must include six elements. No exceptions, no workarounds, no "we are a small brand" exemptions.
1. Product identity statement on the principal display panel (front of the package). This tells the consumer what the product is: "Hydrating Face Serum," not a brand name alone.
2. Net quantity of contents on the principal display panel, in both metric and US customary units. "30 mL / 1.0 fl oz" is correct. "30 mL" alone is not.
3. Name and place of business of the manufacturer, packer, or distributor. For imported products, this is typically the US-based importer or distributor.
4. Ingredient declaration on the information panel (back or side), listing all ingredients in descending order of predominance using INCI nomenclature.
5. Material facts and directions including any warnings required for the product category. Think: "Avoid contact with eyes" for products used near the eye area.
6. Country of origin for imported products. "Made in Korea" or "Product of Republic of Korea" must be conspicuous and permanent.
The minimum type size for required label information is 1/16 of an inch (about 4.5 pt font). Korean ODM packaging sometimes prints ingredient lists so small they border on illegible. If CBP officers cannot read your ingredient list, they can flag the product as misbranded.
INCI Names: Your Korean COA Is Not Enough
Korean Certificates of Analysis (COAs) list ingredients using Korean Cosmetic Ingredient Codex (KCII) nomenclature. US labels require INCI names as defined by the Personal Care Products Council (PCPC), formerly the CTFA. These two systems overlap about 80% of the time, but the 20% divergence is where founders get burned.
Common mismatches include botanical extracts. Your Korean COA might list "Centella Asiatica Extract" while the correct US INCI name is "Centella Asiatica Leaf Extract" or "Centella Asiatica (Gotu Kola) Extract" depending on the plant part used. Fermented ingredients, a K-beauty staple, get even trickier. "Galactomyces Ferment Filtrate" has a specific INCI entry that differs from what some Korean manufacturers write on their COAs.
The fix is straightforward but tedious: cross-reference every single ingredient against the PCPC International Cosmetic Ingredient Dictionary (the "INCI Dictionary"). If an ingredient has no INCI name, use names established by the USP, Food Chemical Codex, or USAN, in that order of preference. Your US regulatory consultant or responsible person should handle this conversion. Do not rely on Google Translate or your ODM's English-language COA without verification.
Is Your Sunscreen a Cosmetic or a Drug?
In the US, any product containing UV filters and making sun protection claims is regulated as an over-the-counter (OTC) drug, not a cosmetic. This is the single biggest classification gap between Korean and US regulations. Korea regulates sunscreen as a "functional cosmetic." The US treats it as a drug. The labeling requirements are completely different.
A US-compliant sunscreen label requires a Drug Facts panel listing active ingredients (UV filters) separately from inactive ingredients, with specific formatting the FDA mandates down to font size and line spacing. The Drug Facts panel must include: active ingredients and their purposes, uses, warnings (including "skin cancer/skin aging alert" for broad-spectrum SPF 15+), directions, and inactive ingredients.
If your Korean tinted moisturizer or BB cream contains SPF and you plan to market it with sun protection claims in the US, you cannot simply slap a bilingual label over the Korean packaging. You need a Drug Facts panel. Period. Some founders dodge this by removing all SPF claims from their US packaging, but if the product contains UV filters and any implication of sun protection exists in your marketing, the FDA can still classify it as an unapproved new drug.
MoCRA's New Labeling Layer
MOCRA, the US federal law requiring cosmetic facility registration and product listing (FDA overview), added new labeling obligations that took effect starting in 2024 and continue rolling out through 2026.
The most impactful change for K-beauty founders: every cosmetic product label must now include domestic contact information for a responsible person. This means a US address, US phone number, or electronic contact (like an email) where consumers and the FDA can report adverse events. Your Korean ODM's Incheon factory address does not count.
If you are using a third-party fulfillment center or Amazon FBA, your registered agent or US distributor serves as the responsible person. Their contact information goes on the label. This is non-negotiable. Products without a domestic responsible person identified on the label are considered misbranded under MoCRA.
Additionally, MoCRA requires adverse event records to be maintained for six years. Make sure your responsible person has a system for receiving and documenting consumer complaints. This is not just a label issue; it is an operational commitment that your label physically represents.
How Do You Handle Country of Origin Marking?
US Customs and Border Protection (CBP) requires country of origin marking on every imported product under 19 U.S.C. § 1304. For cosmetics manufactured in Korea, the marking must be "Made in Korea," "Product of Korea," or "Made in Republic of Korea." It must be conspicuous, legible, permanent, and in English.
Here is where it gets nuanced: if your product is manufactured in Korea but packaged or labeled in the US, the country of origin is still Korea. "Assembled in USA with Korean ingredients" is not an acceptable substitute and can trigger a CBP marking violation. If you are doing any co-manufacturing where some steps happen in the US and some in Korea, consult a customs broker to determine the correct country of origin under substantial transformation rules.
Sticker labels applied after import are acceptable for country of origin marking, but they must be permanent (not easily removable by the consumer) and placed where a buyer would normally look. Tucking a tiny "Made in Korea" sticker under the box flap does not meet the conspicuousness standard.
The Pre-Shipment Label Audit That Saves You $20K
A professional label compliance review costs $200 to $500 per SKU. A customs hold with daily storage fees, re-labeling costs, re-inspection, and a missed launch window can easily run $10,000 to $30,000. The math is not complicated.
Before your ODM prints final packaging, send the label artwork to a US regulatory consultant for review. This person checks all six FDA-required elements, verifies INCI name accuracy, confirms type size compliance, reviews the bilingual consistency, and flags any claims that could reclassify your product as a drug. Turn this around in one to two weeks, and hand the marked-up proof back to your ODM before they run the print.
Build this step into your production timeline from day one. Do not treat it as an afterthought. Your ODM will ask you to approve packaging artwork early in the process, often before stability testing is complete. Approve the design layout early, but lock the regulatory text only after your US compliance review is done. This two-track approach keeps production moving while protecting your launch from a last-minute labeling disaster.
Frequently Asked Questions
Can I sell Korean cosmetics with only Korean labels in Korean grocery stores in the US?
No. All cosmetics sold in the United States must comply with FDA labeling requirements regardless of where they are sold or who the target customer is. Korean grocery stores, H-Marts, and online marketplaces are all subject to the same federal regulations. Products with Korean-only labels are considered misbranded under the FD&C Act. Some retailers add English sticker labels to imported products, which is acceptable if the sticker includes all FDA-required information and is permanently affixed.
Do I need a separate FDA product listing for each shade or size variant?
Under MoCRA, each cosmetic product requires a product listing with the FDA. Shade variants with different ingredient lists (different colorants, for example) count as separate products and need separate listings. Size variants with identical formulations can typically be listed under the same product listing. Check the FDA's SPL (Structured Product Labeling) guidance for cosmetic product listing to confirm your specific situation.
What if my Korean ODM changes the formula after I finalize my US labels?
This happens more often than you would expect, especially with raw material substitutions due to supply chain issues. Your manufacturing agreement should include a clause requiring written approval before any formula change. If a change occurs after label printing, you face two options: reprint labels with the updated ingredient list (costly but compliant), or reject the batch and require the original formula. Selling products with an ingredient list that does not match the actual contents is a federal violation under the FD&C Act, and MoCRA's adverse event reporting requirements make this riskier than ever.
We have worked with indie K-beauty founders across 50+ launches over the last seven years. The single most common mistake? Treating US labeling as a translation job instead of a regulatory project. By the time customs flags it, the re-label bill and storage fees have already eaten your first-batch margin. If your packaging artwork is sitting in your inbox right now waiting for approval, take 15 minutes and walk through it with someone who has done this before. Book a free gut-check call here.
